How LeMaitre Vascular, Inc. stacks up

LMAT · against 418 other Healthcare companies of similar size

Overall

79/ 100

Near the top of its peers.

Ranked #21 of 419 · scores higher than 94% of peers

Bars: peers in each 10-point band of the overall score

46 peers with an overall score of 70–79, including LMAT · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#193 of 427Score 59 / 100 · beats 54%Growth#100 of 385Score 74 / 100 · beats 73%Profitability#43 of 420Score 90 / 100 · beats 89%Risk#34 of 429Lower relative risk · safety 93 · beats 92%

Ranking by overall score

Top 5 and the companies ranked around LMAT

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	BB Biotech AGBBZA.DE · Europe	3.1B EUR (≈$3.4B)	100		100	100	0 / 2
2	Lakefront Biotherapeutics NVLKFT · US-listed	2.1B USD	96	96	99	93	0 / 2
2	Zealand Pharma A/SZEAL.CO · Europe	15.6B DKK (≈$2.3B)	96	96	99	96	0 / 2
4	Innoviva, Inc.INVA · US-listed	1.5B USD	93	94	91	93	0 / 2
5	PharmaResearch Co., Ltd.214450.KQ · South Korea	2.29T KRW (≈$1.6B)	88	83	90	96	0 / 2
⋯
14	Procter & Gamble Health LimitedPGHL.NS · India	97.3B INR (≈$1.2B)	80	57	—	100	0 / 2
21	Tonghua Dongbao Pharmaceutical Co., Ltd.600867.SS · China	15.6B CNY (≈$2.2B)	79	86	81	73	0 / 2
21	ADMA Biologics, Inc.ADMA · US-listed	2.5B USD	79	81	67	98	0 / 2
21	Top Glove Corporation Bhd.BVA.SI · Singapore	2.4B SGD (≈$1.8B)	79	71	88	88	0 / 2
21	LeMaitre Vascular, Inc.LMAT · US-listed	1.8B USD	79	59	74	90	0 / 2
21	PT Mitra Keluarga Karyasehat TbkMIKA.JK · Southeast Asia	18.29T IDR (≈$1.1B)	79	93	57	95	0 / 2
26	Harmony Biosciences Holdings, Inc.HRMY · US-listed	2.2B USD	78	92	75	95	1 / 2
27	Zhejiang Jolly Pharmaceutical Co.,LTD300181.SZ · China	8.7B CNY (≈$1.2B)	77	88	72	89	1 / 2
27	Nippon Shinyaku Co., Ltd.4516.T · Japan	226.3B JPY (≈$1.5B)	77	99	42	83	0 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…